Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Alistair Nichol, Yaseen M. Arabi et al.|medRxiv|2021Cited by 137
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trialLennie Derde, Ville Pettilä, Anthony Gordon et al.|Thorax|2025Cited by 12
Antibiotic De-Escalation Practices in the Intensive Care Unit: A Multicenter Observational StudyAsad E. Patanwala, Arwa Abu Sardaneh, Jan‐Willem C. Alffenaar et al.|Annals of Pharmacotherapy|2024Cited by 1